The circMTCL1/miR-145-5p/BMP3 axis suppresses colorectal cancer cell growth by mediating the MAPK signaling pathway.

IF 4.7 4区 医学 Q2 ONCOLOGY
Liyuan Liu, Dan Jiang, Yongcun Jia, Yuqing Dong, Wei Zhao
{"title":"The circMTCL1/miR-145-5p/BMP3 axis suppresses colorectal cancer cell growth by mediating the MAPK signaling pathway.","authors":"Liyuan Liu, Dan Jiang, Yongcun Jia, Yuqing Dong, Wei Zhao","doi":"10.1007/s12032-026-03414-3","DOIUrl":null,"url":null,"abstract":"<p><p>Circular RNAs play key roles in colorectal cancer (CRC). Here, we examine the function and underlying mechanism of circMTCL1 in CRC. The expression of circMTCL1 in CRC tissues and cell lines were detected by quantitative real-time PCR (qRT-PCR). The function of circMTCL1 was elucidated through overexpression and knockdown studies. Furthermore, a combination of Fluorescence in situ hybridization (FISH), nuclear-cytoplasmic fractionation, RNA immunoprecipitation (RIP), qRT-PCR, Western blotting, and dual-luciferase reporter assays was employed to elucidate the tumor-suppressive mechanism of circMTCL1 in CRC. circMTCL1 was significantly downregulated in CRC tissues compared to adjacent normal tissues, showing a 17.08-fold decrease (P < 0.001). It functioned as a competing endogenous RNA (ceRNA) by specifically binding to miR-145-5p, thereby modulating the expression of Bone Morphogenetic Protein 3 (BMP3). Overexpression of circMTCL1 markedly inhibited the proliferation, migration, and invasion of CRC cells, resulting in a 3.76-fold decrease in proliferation (P < 0.001), and 1.58-fold and 2.00-fold decreases in migration and invasion, respectively (P < 0.001). Furthermore, circMTCL1 overexpression upregulated BMP3 expression by 1.60-fold (P < 0.001). Further investigation revealed that circMTCL1 regulates tumor progression by suppressing the activation of the MAPK signaling pathway. circMTCL1 acts as a tumor suppressor in CRC. Its mechanism likely involves sponging miR-145-5p to regulate BMP3 expression and modulating the MAPK signaling pathway. These findings provide a new perspective on the pathogenesis of CRC and identify a potential therapeutic target for clinical intervention.</p>","PeriodicalId":18433,"journal":{"name":"Medical Oncology","volume":"43 11","pages":""},"PeriodicalIF":4.7000,"publicationDate":"2026-10-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medical Oncology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s12032-026-03414-3","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Circular RNAs play key roles in colorectal cancer (CRC). Here, we examine the function and underlying mechanism of circMTCL1 in CRC. The expression of circMTCL1 in CRC tissues and cell lines were detected by quantitative real-time PCR (qRT-PCR). The function of circMTCL1 was elucidated through overexpression and knockdown studies. Furthermore, a combination of Fluorescence in situ hybridization (FISH), nuclear-cytoplasmic fractionation, RNA immunoprecipitation (RIP), qRT-PCR, Western blotting, and dual-luciferase reporter assays was employed to elucidate the tumor-suppressive mechanism of circMTCL1 in CRC. circMTCL1 was significantly downregulated in CRC tissues compared to adjacent normal tissues, showing a 17.08-fold decrease (P < 0.001). It functioned as a competing endogenous RNA (ceRNA) by specifically binding to miR-145-5p, thereby modulating the expression of Bone Morphogenetic Protein 3 (BMP3). Overexpression of circMTCL1 markedly inhibited the proliferation, migration, and invasion of CRC cells, resulting in a 3.76-fold decrease in proliferation (P < 0.001), and 1.58-fold and 2.00-fold decreases in migration and invasion, respectively (P < 0.001). Furthermore, circMTCL1 overexpression upregulated BMP3 expression by 1.60-fold (P < 0.001). Further investigation revealed that circMTCL1 regulates tumor progression by suppressing the activation of the MAPK signaling pathway. circMTCL1 acts as a tumor suppressor in CRC. Its mechanism likely involves sponging miR-145-5p to regulate BMP3 expression and modulating the MAPK signaling pathway. These findings provide a new perspective on the pathogenesis of CRC and identify a potential therapeutic target for clinical intervention.

circMTCL1/miR-145-5p/BMP3轴通过介导MAPK信号通路抑制结直肠癌细胞生长。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Medical Oncology
Medical Oncology 医学-肿瘤学
CiteScore
4.20
自引率
2.90%
发文量
259
审稿时长
1.4 months
期刊介绍: Medical Oncology (MO) communicates the results of clinical and experimental research in oncology and hematology, particularly experimental therapeutics within the fields of immunotherapy and chemotherapy. It also provides state-of-the-art reviews on clinical and experimental therapies. Topics covered include immunobiology, pathogenesis, and treatment of malignant tumors.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书